Trials / Unknown
UnknownNCT03068208
Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians
Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians: Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Efficacy of Methylene blue mediated Photodynamic therapy for primary localized cutaneous amyloidosis treatment in Asians, pilot study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Methylene blue-mediated photodynamic therapy | The 2% MB aqueous solution was applied to the lesion until saturation occurred, followed by a occlusive dressing and rest period of 30 minutes. After the rest period, the lesion was immediately illuminated with incoherent red light (peak emission spectrum at 630-640 nm) |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2018-04-30
- Completion
- 2018-06-30
- First posted
- 2017-03-01
- Last updated
- 2017-03-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03068208. Inclusion in this directory is not an endorsement.